BIOCON
Quarterly Results Analysis [Sep2025]
BIOCON Quarterly Results
| Consolidated | Sep2025 UnAudited |
Jun2025 UnAudited |
Mar2025 UnAudited |
Dec2024 UnAudited |
Sep2024 UnAudited |
Jun2024 UnAudited |
Mar2024 UnAudited |
Dec2023 UnAudited |
|---|---|---|---|---|---|---|---|---|
| Revenues | ₹4,296 Cr | ₹3,942 Cr | ₹4,417 Cr | ₹3,821 Cr | ₹3,590 Cr | ₹3,433 Cr | ₹3,917 Cr | ₹3,954 Cr |
| Expenses | ₹3,460 Cr | ₹3,193 Cr | ₹3,339 Cr | ₹3,070 Cr | ₹2,905 Cr | ₹2,813 Cr | ₹3,001 Cr | ₹3,027 Cr |
| Operating Income | ₹835 Cr | ₹749 Cr | ₹1,078 Cr | ₹752 Cr | ₹685 Cr | ₹620 Cr | ₹916 Cr | ₹927 Cr |
| Other Income | ₹93 Cr | ₹80 Cr | ₹37 Cr | ₹35 Cr | ₹33 Cr | ₹1,135 Cr | ₹49 Cr | ₹566 Cr |
| Interest | ₹272 Cr | ₹277 Cr | ₹212 Cr | ₹223 Cr | ₹226 Cr | ₹236 Cr | ₹227 Cr | ₹267 Cr |
| Depreciation | ₹473 Cr | ₹455 Cr | ₹436 Cr | ₹425 Cr | ₹420 Cr | ₹405 Cr | ₹407 Cr | ₹415 Cr |
| Profit Before Tax | ₹171 Cr | ₹97 Cr | ₹487 Cr | ₹156 Cr | ₹98 Cr | ₹1,146 Cr | ₹322 Cr | ₹832 Cr |
| Profit After Tax | ₹133 Cr | ₹89 Cr | ₹459 Cr | ₹81 Cr | ₹27 Cr | ₹862 Cr | ₹226 Cr | ₹777 Cr |
| EPS | ₹0.63 | ₹0.23 | ₹2.87 | ₹0.21 | ₹-0.13 | ₹5.49 | ₹1.13 | ₹5.50 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| BIOCON | -2.9% | -6.5% | -1.7% |
| SUN PHARMACEUTICAL INDUSTRIES | -6.8% | -7.6% | -4.7% |
| DIVIS LABORATORIES | -6.6% | -5.8% | 4.5% |
| CIPLA | -4.8% | -8.1% | -3.9% |
| TORRENT PHARMACEUTICALS | 0.9% | 5.7% | 27.3% |
| DR REDDYS LABORATORIES | -2% | -8.8% | -12.9% |
| MANKIND PHARMA | -4% | -0.9% | -18.4% |
| ZYDUS LIFESCIENCES | -3% | -4.5% | -10.5% |
| LUPIN | -0.5% | 2.3% | 2.4% |
BIOCON Quarterly Revenues
| Revenues | |
|---|---|
| Q-o-Q | 8.97 % |
| Y-o-Y | 19.64 % |
| Quarters | Revenues | % Change | |
|---|---|---|---|
| Sep2025 | ₹4,296 Cr | 8.97 | |
| Jun2025 | ₹3,942 Cr | -10.76 | |
| Mar2025 | ₹4,417 Cr | 15.59 | |
| Dec2024 | ₹3,821 Cr | 6.43 | |
| Sep2024 | ₹3,590 Cr | 4.59 | |
| Jun2024 | ₹3,433 Cr | -12.36 | |
| Mar2024 | ₹3,917 Cr | -0.93 | |
| Dec2023 | ₹3,954 Cr | - | |
BIOCON Quarterly Operating Profit
| Operating Profit | |
|---|---|
| Q-o-Q | 11.55 % |
| Y-o-Y | 21.89 % |
| Quarters | Operating Profit | % Change | |
|---|---|---|---|
| Sep2025 | ₹835 Cr | 11.55 | |
| Jun2025 | ₹749 Cr | -30.54 | |
| Mar2025 | ₹1,078 Cr | 43.42 | |
| Dec2024 | ₹752 Cr | 9.69 | |
| Sep2024 | ₹685 Cr | 10.48 | |
| Jun2024 | ₹620 Cr | -32.26 | |
| Mar2024 | ₹916 Cr | -1.18 | |
| Dec2023 | ₹927 Cr | - | |
| Operating Margins | |
|---|---|
| Q-o-Q | 2.37 % |
| Y-o-Y | 1.89 % |
| Quarters | Operating Margin% | % Change | |
|---|---|---|---|
| Sep2025 | 19.45% | 2.37 | |
| Jun2025 | 19% | -22.16 | |
| Mar2025 | 24.41% | 24.10 | |
| Dec2024 | 19.67% | 3.04 | |
| Sep2024 | 19.09% | 5.64 | |
| Jun2024 | 18.07% | -22.71 | |
| Mar2024 | 23.38% | -0.26 | |
| Dec2023 | 23.44% | - | |
BIOCON Quarterly Profit After Tax
| Profit After Tax(PAT) | |
|---|---|
| Q-o-Q | 48.88 % |
| Y-o-Y | 390.04 % |
| Quarters | Profit After Tax | % Change | |
|---|---|---|---|
| Sep2025 | ₹133 Cr | 48.88 | |
| Jun2025 | ₹89 Cr | -80.58 | |
| Mar2025 | ₹459 Cr | 466.46 | |
| Dec2024 | ₹81 Cr | 199.26 | |
| Sep2024 | ₹27 Cr | -96.86 | |
| Jun2024 | ₹862 Cr | 282.00 | |
| Mar2024 | ₹226 Cr | -70.98 | |
| Dec2023 | ₹777 Cr | - | |
| PAT Margins | |
|---|---|
| Q-o-Q | 36.73 % |
| Y-o-Y | 312.00 % |
| Quarters | PAT Margin(%) | % Change | |
|---|---|---|---|
| Sep2025 | 3.09 % | 36.73 | |
| Jun2025 | 2.26 % | -78.27 | |
| Mar2025 | 10.4 % | 390.57 | |
| Dec2024 | 2.12 % | 182.67 | |
| Sep2024 | 0.75 % | -97.01 | |
| Jun2024 | 25.1 % | 335.76 | |
| Mar2024 | 5.76 % | -70.70 | |
| Dec2023 | 19.66 % | - | |
BIOCON Quarterly Earnings Per Share (EPS)
| EPS | |
|---|---|
| Q-o-Q | 173.91 % |
| Y-o-Y | Positive |
| Quarters | EPS | % Change | |
|---|---|---|---|
| Sep2025 | ₹0.63 | 173.91 | |
| Jun2025 | ₹0.23 | -91.99 | |
| Mar2025 | ₹2.87 | 1,266.67 | |
| Dec2024 | ₹0.21 | Positive | |
| Sep2024 | ₹-0.13 | Negative | |
| Jun2024 | ₹5.49 | 385.84 | |
| Mar2024 | ₹1.13 | -79.45 | |
| Dec2023 | ₹5.5 | - | |
You may also like the below Video Courses